Study population
| Age | Median 71.5 (range 17-90) |
|---|---|
| Surgery - Radical vulvectomy - Partial vulvectomy - Vulvectomy - Local Excision - Plastic surgery | 104 (57.5%) 69 (38.1%) 3 (1.66%) 4 (2.2%) 1 (0.6%) |
| Staging - pT1a - pT1b - pT2 - pT3 - pNx - pN0 - pN+ | 15 (8.3%) 137 (75.7%) 27 (14.9%) 2 (1.1%) 19 (10.5%) 45 (24.9%) 117 (64.6%) |
| Maximal tumor diameter- >4cm - <4cm | 107 (59.1%) 74 (40.9%) |
| Grading - G1 - G2 - G3 - NA | 17 (9.4%) 113 (62.4%) 47 (26.0%) 4 (2.2%) |
| Histology - Squamous cell carcinoma - Other | 176 (97.2%) 5 (2.8%) |
| Radiotherapy prescription: - Dose on the surgical bed - Dose on the residual tumor (if any) - Dose on the lymph nodes (if prescribed) | 45-70 Gy (1.8-2 Gy/die) 50-70 Gy (1.8-2 Gy/die) 45-70.4 Gy (1.8-2 Gy/die) |
| Concomitant chemotherapy - Yes - No | 61 (33.7%) 120 (66.3%) |
| Toxicity G3-4 - Acute skin - Chronic skin - Acute lymphoedema - Chronic lymphoedema - Vaginal stenosis | 40 (22.1%) 4 (2.2%) 0 (0%) 2 (1.1%) 1 (0.6%) |
NA: not available